From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 8, doi. 10.1002/pu
- Publication type:
- Article
Works matching IS 10685308 AND DT 2015 AND VI 26 AND IP 12
Results: 7
1
2
RESEARCH ROUNDUP.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 7, doi. 10.1002/pu.30102
- Publication type:
- Article
3
Antidepressants block effect of D-cycloserine in OCD treatment.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 4, doi. 10.1002/pu.30101
- Publication type:
- Article
4
Omega-3 fatty acids may prevent long-term progression to psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 3, doi. 10.1002/pu.30100
- Publication type:
- Article
5
Cushing's syndrome with concurrent use of fluvoxamine, budesonide.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
6
Longitudinal study shows no effect of supplements on cognition in elderly.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 1, doi. 10.1002/pu.30098
- Publication type:
- Article
7
FDA approves revised prescribing for clozapine; new REMS in effect.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 1, doi. 10.1002/pu.30097
- By:
- Publication type:
- Article